Orphazyme provides regulatory update following Type A meeting with FDA on arimoclomol in Niemann-Pick disease type C
Orphazyme A/SCompany announcement        No. 24/2021Inside informationCompany Registration No. 32266355 Progress made in understanding potential resolution of…
playX Receives the ‘Enterprise Award’ at the Asia Golden Star Awards in Tokyo
Zhibao Technology Announces Receipt of Nasdaq Deficiency Letter
Fairfax County and Penzance Officials Break Ground on Next-Generation Digital Infrastructure Project to Power the World’s Deep Tech Future
Dynamic Expands to Loudoun County, Virginia — Meeting Customer Demand for Secure, Sustainable ITAD and Data Center Services in “Data Center Alley”
Prompt Infrastructure as the New Battleground for AI Assistants